FRANKFURT--The following is a summary of analysts' forecasts for
Sanofi SA (SNY) third-quarter results, based on a poll of nine
analysts conducted by Dow Jones Newswires (figures in million
euros, EPS and target price in euro, according to IFRS). Earnings
figures are scheduled to be released October 28.
===
Net Business Business Business
3rd Quarter sales Oper. Income net income EPS
AVERAGE 8,875 2,674 1,933 1.47
Prev. Year 8,432 2,476 1,789 1.35
+/- in % +5.2 +8.0 +8.0 +8.6
MEDIAN 8,836 2,650 1,926 1.46
Maximum 9,076 2,791 2,004 1.53
Minimum 8,768 2,596 1,879 1.43
Amount (a) 9 9 8 9
Baader-Helvea 8,836 2,693 1,927 1.47
Bernstein 9,076 2,791 2,004 1.53
CM-CIC Securities 8,850 2,650 1,930 1.46
Cowen and Company 8,835 2,596 1,879 1.43
Credit Suisse 8,768 2,615 -- 1.43
Deutsche Bank 8,833 2,695 1,913 1.46
Jefferies 8,967 2,786 1,996 1.52
Morgan Stanley 8,911 2,607 1,888 1.44
Target price Rating
AVERAGE 93.75 positive 5
Prev. Quarter 84.40 neutral 0
+/- in % +11 negative 0
MEDIAN 94.00
Maximum 97.00
Minimum 90.00
Amount (a) 4
Baader-Helvea 90.00 Buy
Credit Suisse 95.00 Outperform
Deutsche Bank 93.00 Buy
Jefferies 97.00 Buy
Morgan Stanley -- Overweight
===
Year-earlier figures are as reported by the company.
(a) Including anonymous estimates from one more analyst.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires